Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP253221.RAgnnqSpPEY8_z2J2ol-GlTBZE8oVlpBjpTnpbcJvJtwU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP253221.RAgnnqSpPEY8_z2J2ol-GlTBZE8oVlpBjpTnpbcJvJtwU130_assertion type Assertion NP253221.RAgnnqSpPEY8_z2J2ol-GlTBZE8oVlpBjpTnpbcJvJtwU130_head.
- NP253221.RAgnnqSpPEY8_z2J2ol-GlTBZE8oVlpBjpTnpbcJvJtwU130_assertion wasGeneratedBy ECO_0000203 NP253221.RAgnnqSpPEY8_z2J2ol-GlTBZE8oVlpBjpTnpbcJvJtwU130_provenance.
- NP253221.RAgnnqSpPEY8_z2J2ol-GlTBZE8oVlpBjpTnpbcJvJtwU130_assertion wasDerivedFrom befree-20150227 NP253221.RAgnnqSpPEY8_z2J2ol-GlTBZE8oVlpBjpTnpbcJvJtwU130_provenance.
- NP253221.RAgnnqSpPEY8_z2J2ol-GlTBZE8oVlpBjpTnpbcJvJtwU130_assertion SIO_000772 17091508 NP253221.RAgnnqSpPEY8_z2J2ol-GlTBZE8oVlpBjpTnpbcJvJtwU130_provenance.
- NP253221.RAgnnqSpPEY8_z2J2ol-GlTBZE8oVlpBjpTnpbcJvJtwU130_assertion evidence source_evidence_literature NP253221.RAgnnqSpPEY8_z2J2ol-GlTBZE8oVlpBjpTnpbcJvJtwU130_provenance.
- NP253221.RAgnnqSpPEY8_z2J2ol-GlTBZE8oVlpBjpTnpbcJvJtwU130_assertion description "[The ASC-US follow-up study (2319 cases with 625 having biopsy results) showed that the rate of CIN III+ in HPV +/- cases was 7.8%/1.4%, and of CIN II+ was 17.5%/4.3%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253221.RAgnnqSpPEY8_z2J2ol-GlTBZE8oVlpBjpTnpbcJvJtwU130_provenance.